Clinical Trial Update: ALG.APV-527 First-in-human Study [Phase 1, Phase 2]

View source ↗

Summary

First-in-human study update for ALG.APV-527 investigating solid tumors in Phase 1/Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• ALG.APV-527

Snippet

Sponsor: Aptevo Therapeutics | Conditions: Solid Tumor | Phase 1, Phase 2 | Status: UNKNOWN